Links to publications that use this kit:
Eraydin et al., Comparison of Neuropeptide Innervation in Allergic and Nonallergic Rhinitis.J Otol Rhinol 2014, 3:4
Cobo M, Anderson P, Benabdellah K, et al. Mesenchymal stem cells expressing vasoactive intestinal peptide ameliorate symptoms in a model of chronic multiple sclerosis. Cell Transplant. 2013;22(5):839-54.
Herberth et al. Relation between stressful life events, neuropeptides and cytokines: results from the LISA birth cohort studyPediatr Allergy Immunol. 2008 Dec;19(8):722-9.
Sample et al. Functional adaptation to loading of a single bone is neuronally regulated and involves multiple bones.J Bone Miner Res. 2008 Sep;23(9):1372-81.
Delgado et al. In Vivo Delivery of Lentiviral Vectors Expressing Vasoactive Intestinal Peptide Complementary DNA as Gene Therapy for Collagen-Induced ArthritisArthritis Rheum. 2008 Apr;58(4):1026-37.Juarranz et al. Differential Expression of Vasoactive Intestinal Peptide and Its Functional Receptors in Human Osteoarthritic and Rheumatoid Synovial FibroblastsArthritis Rheum. 2008 Apr;58(4):1086-95.
Valdehita et al. Vasoactive intestinal peptide (VIP) increases vascular endothelial growth factor (VEGF) expression and secretion in human breast cancer cellsRegul Pept. 2007 Dec 4;144(1-3):101-8.
Fernandez-Martinez et al. Vasoactive intestinal peptide induces cyclooxygenase-2 expression through nuclear factor-kB in human prostate cell lines Differential time-dependent responses in cancer progressionMol Cell Endocrinol. 2007 May 30;270(1-2):8-16.
Sun et al. Altered expression of vasoactive intestinal peptide receptors in T lymphocytes and aberrant Th1 immunity in multiple sclerosis.Int Immunol. 2006 Dec;18(12):1691-700.
Herberth et al. Association of neuropeptides with Th1/Th2 balance and allergic sensitization in children.Clin Exp Allergy. 2006 Nov;36(11):1408-16.
Collado et al. Hypoxia regulation of expression and angiogenic effects of vasoactive intestinal peptide (VIP) and VIP receptors in LNCaP prostate cancer cellsMol Cell Endocrinol. 2006 Apr 25;249(1-2):116-22.
Grimsholm et al. Levels of gastrin-releasing peptide and substance P in synovial fluid and serum correlate with levels of cytokines in rheumatoid arthritis.Arthritis Res Ther. 2005;7(3):R416-26.
